Hong Kong · Delayed Price · Currency is HKD Kintor Pharmaceutical Statistics
Total Valuation
HKG:9939 has a market cap or net worth of HKD 834.54 million. The enterprise value is 952.62 million.
| Market Cap | 834.54M |
| Enterprise Value | 952.62M |
Important Dates
The last earnings date was Wednesday, August 19, 2026.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:9939 has 493.81 million shares outstanding. The number of shares has increased by 4.42% in one year.
| Current Share Class | 493.81M |
| Shares Outstanding | 493.81M |
| Shares Change (YoY) | +4.42% |
| Shares Change (QoQ) | +7.23% |
| Owned by Insiders (%) | 12.11% |
| Owned by Institutions (%) | 3.86% |
| Float | 378.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.18 |
| PB Ratio | 6.62 |
| P/TBV Ratio | 53.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.26, with a Debt / Equity ratio of 1.22.
| Current Ratio | 0.26 |
| Quick Ratio | 0.19 |
| Debt / Equity | 1.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.89 |
| Interest Coverage | -45.47 |
Financial Efficiency
Return on equity (ROE) is -118.45% and return on invested capital (ROIC) is -39.45%.
| Return on Equity (ROE) | -118.45% |
| Return on Assets (ROA) | -30.31% |
| Return on Invested Capital (ROIC) | -39.45% |
| Return on Capital Employed (ROCE) | -126.73% |
| Weighted Average Cost of Capital (WACC) | 1.31% |
| Revenue Per Employee | 739,031 |
| Profits Per Employee | -1.81M |
| Employee Count | 123 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 6.40 |
Taxes
| Income Tax | -6.46M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.92% in the last 52 weeks. The beta is -0.57, so HKG:9939's price volatility has been lower than the market average.
| Beta (5Y) | -0.57 |
| 52-Week Price Change | -27.92% |
| 50-Day Moving Average | 1.84 |
| 200-Day Moving Average | 2.37 |
| Relative Strength Index (RSI) | 41.14 |
| Average Volume (20 Days) | 1,047,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:9939 had revenue of HKD 90.90 million and -222.38 million in losses. Loss per share was -0.46.
| Revenue | 90.90M |
| Gross Profit | 39.14M |
| Operating Income | -198.99M |
| Pretax Income | -228.84M |
| Net Income | -222.38M |
| EBITDA | -155.30M |
| EBIT | -198.99M |
| Loss Per Share | -0.46 |
Balance Sheet
The company has 36.13 million in cash and 154.22 million in debt, with a net cash position of -118.09 million or -0.24 per share.
| Cash & Cash Equivalents | 36.13M |
| Total Debt | 154.22M |
| Net Cash | -118.09M |
| Net Cash Per Share | -0.24 |
| Equity (Book Value) | 126.10M |
| Book Value Per Share | 0.26 |
| Working Capital | -155.43M |
Cash Flow
In the last 12 months, operating cash flow was -174.22 million and capital expenditures 182,407, giving a free cash flow of -174.04 million.
| Operating Cash Flow | -174.22M |
| Capital Expenditures | 182,407 |
| Depreciation & Amortization | 36.94M |
| Net Borrowing | -56.01M |
| Free Cash Flow | -174.04M |
| FCF Per Share | -0.35 |
Margins
Gross margin is 43.05%, with operating and profit margins of -218.91% and -244.64%.
| Gross Margin | 43.05% |
| Operating Margin | -218.91% |
| Pretax Margin | -251.75% |
| Profit Margin | -244.64% |
| EBITDA Margin | -170.84% |
| EBIT Margin | -218.91% |
| FCF Margin | n/a |
Dividends & Yields
HKG:9939 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.42% |
| Shareholder Yield | -4.42% |
| Earnings Yield | -26.65% |
| FCF Yield | -20.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |